Evidence map›Paper›PMID 40476095›Full record

ArticleCureus2025

Isolated Splenic Metastasis and Splenic Bed Recurrence From Endometrial Carcinoma: A Rare Case.

Aasef M Mansoor

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Aasef M MansoorRadiology, Salmaniya Medical Complex, Manama, BHR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Papillary serous carcinoma is a rare and aggressive subtype of endometrial cancer with a strong predilection for extrauterine spread. Although metastasis typically involves the peritoneum, lymph nodes, and lungs, isolated splenic metastases are exceedingly rare. We report the case of a 66-year-old woman initially diagnosed with papillary serous endometrial carcinoma following an episode of postmenopausal bleeding. She underwent surgical staging with hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymphadenectomy, followed by adjuvant chemotherapy. Two years later, she presented with non-specific abdominal discomfort, and imaging revealed a solitary splenic lesion. A splenectomy was performed, and histopathology confirmed metastatic papillary serous carcinoma. The patient remained stable until a further year later when she was re-presented with fatigue and left upper quadrant pain. Imaging demonstrated a soft tissue mass in the splenic bed, and histopathological analysis confirmed the recurrence of the known malignancy. This case underscores the potential for late, isolated splenic metastasis and recurrence in the splenic bed after splenectomy which is exceptionally uncommon. It highlights the importance of long-term surveillance and the consideration of atypical metastatic patterns in patients with serous endometrial cancer. This report adds to the limited literature and reinforces the value of individualized, multidisciplinary management in such complex clinical scenarios.

Indexed as

endometrial cancerisolated metastasislong-term surveillancepapillary serous carcinomapostmenopausal bleedingrare metastasisrecurrenceserous endometrial cancersplenectomysplenic metastasis

Identifiers

PMID40476095
PMCPMC12139316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.